Deep expertise across a broad spectrum of testing techniques for CGT Cell and gene therapy clinical trials require a robust and varied selection of lab services and testing platforms - from molecular capabilities like PCR and NGS to immunohistochemistry, flow cytometry and immunoassays. ICON Specialty, Bioanalytical and CLIA laboratories are equipped with the technology and expertise to support successful CGT development programs in oncology, CNS and rare diseases. ICONplc.com/labshttps://www.iconplc.com/services/laboratories/index.xml